Betalin Therapeutics logo

Betalin Therapeutics

Biological micro-pancreas for insulin-dependent diabetics company

4

Funding Rounds

$5.1m

Money raised

Overview

Biological micro-pancreas for insulin-dependent diabetics company

Funding series

Funding Series Analysis

The company Betalin Therapeutics has raised a total of $2.5m in funding over 4 rounds.

Key Insights:

  • Betalin Therapeutics , April 2019: $2.5m
  • Betalin Therapeutics Seed Funding Round January 2017: $58k
  • Betalin Therapeutics Series A Funding Round April 2019: $2.5m
Betalin Therapeutics logo
Betalin Therapeutics , April 2019 $2.5m
Betalin Therapeutics logo
Betalin Therapeutics Seed Funding Round January 2017 $58k
Betalin Therapeutics logo
Betalin Therapeutics Series A Funding Round April 2019 $2.5m